{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:13:06Z","timestamp":1788883986050,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.tube.2025.102628","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:46:46Z","timestamp":1741322806000},"page":"102628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Integrative exploration of 2-phenylquinolin-4(1H)-one tethered 1,2,3-triazole derivatives: A comprehensive in vitro and in silico investigation towards novel anti-tubercular agents"],"prefix":"10.1016","volume":"152","author":[{"given":"Raut","family":"Mehavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walhekar","family":"Vinayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patil","family":"Ashwini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan Kumar","family":"Jaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohana Vamsi","family":"Nuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhikshapathi","family":"DVRN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9455-7958","authenticated-orcid":false,"given":"Ravindra","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2025.102628_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pneumo.2014.04.001","article-title":"Les tuberculoses extrapulmonaires","volume":"71","author":"Ketata","year":"2015","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.tube.2025.102628_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0213-005X(11)70011-8","article-title":"Present epidemiology of tuberculosis. Prevention and control programs","volume":"29","author":"Orcau","year":"2011","journal-title":"Enferm Infecc Microbiol Cl\u00edn"},{"key":"10.1016\/j.tube.2025.102628_bib3","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.4103\/jfmpc.jfmpc_542_19","article-title":"Prevalence of multidrug resistance tuberculosis in adult patients in India: a systematic review and meta-analysis","volume":"8","author":"Charan","year":"2019","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.tube.2025.102628_bib4","unstructured":"https:\/\/www.who.int\/news\/item\/27-10-2022-tuberculosis-deaths-and-disease-increase-during-the-covid-19-pandemic."},{"key":"10.1016\/j.tube.2025.102628_bib5","unstructured":"https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022\/covid-19-and-tb."},{"key":"10.1016\/j.tube.2025.102628_bib6","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.3390\/jcm12144784","article-title":"COVID-19 and tuberculosis: unveiling the dual threat and shared solutions perspective","volume":"12","author":"Cioboata","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.tube.2025.102628_bib7a","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0970-2113.95320","article-title":"DOTS for TB relapse in India: a systematic review","volume":"29","author":"Azhar","year":"2012","journal-title":"Lung India"},{"issue":"2","key":"10.1016\/j.tube.2025.102628_bib7b","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to first-line antituberculosis drugs","volume":"5","author":"Forget","year":"2006","journal-title":"Expet Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.tube.2025.102628_bib7c","first-page":"S90","article-title":"Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis","volume":"3","author":"Singh","year":"2015","journal-title":"Clin Epidem Global Health"},{"issue":"9","key":"10.1016\/j.tube.2025.102628_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-Resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.tube.2025.102628_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccm.2019.08.001","article-title":"New drugs for the treatment of tuberculosis","volume":"40","author":"Ignatius","year":"2019","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.tube.2025.102628_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007490","article-title":"Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study","volume":"7","author":"Perrin","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.tube.2025.102628_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2025.102628_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/15734064113099990039","article-title":"Synthesis, antibacterial, antifungal and antitubercular activities of N-pyrazolylbenzamide derivatives","volume":"10","author":"Kulkarni","year":"2014","journal-title":"Med Chem"},{"key":"10.1016\/j.tube.2025.102628_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1871523013666140820154843","article-title":"Synthesis, characterization and anti-inflammatory activity of N-(4- phenyl-1, 3-thiazol-2-yl)-N\u2019-phenylureas","volume":"13","author":"Fatima","year":"2014","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"10.1016\/j.tube.2025.102628_bib14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2174\/1386207323999200918114905","article-title":"Synthesis, characterization, antitubercular and anti-inflammatory activity of new pyrazolo[3,4-d]pyrimidines","volume":"24","author":"Kulkarni","year":"2021","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1016\/j.tube.2025.102628_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1573408013666170516143419","article-title":"Pyrazolyl benzamides: synthesis, characterization and potent biological activity, part-2","volume":"14","author":"Ganesh","year":"2018","journal-title":"Curr Enzym Inhib"},{"issue":"12","key":"10.1016\/j.tube.2025.102628_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4172\/2161-0444.1000311","article-title":"Design, synthesis, antimicrobial and anti-inflammatory activity of n-pyrazolyl benzamide derivatives","volume":"5","author":"Fatima","year":"2015","journal-title":"Med Chem"},{"issue":"17","key":"10.1016\/j.tube.2025.102628_bib17","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2174\/1389557517666170707105416","article-title":"Design, synthesis, anti-inflammatory, p38 kinase inhibitory, antimicrobial and antitubercular activities of substituted benzamides","volume":"18","author":"Kulkarni","year":"2018","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"10.1016\/j.tube.2025.102628_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/1573406416666200514084747","article-title":"Novel aminopyrazole tagged hydrazones as anti-tubercular agents: synthesis and molecular docking studies","volume":"17","author":"Thatavarthi","year":"2021","journal-title":"Med Chem"},{"issue":"3","key":"10.1016\/j.tube.2025.102628_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.14233\/ajomc.2020.AJOMC-P272","article-title":"Design, synthesis and evaluation of aryloxybenzylidene hydrazinyl-benzoxazoles\/benzothiazoles analogs as anti-mycobacterial agents","volume":"5","author":"Aruna","year":"2020","journal-title":"Asian J Org Med Chem"},{"issue":"1s","key":"10.1016\/j.tube.2025.102628_bib20","doi-asserted-by":"crossref","first-page":"s58","DOI":"10.5530\/ijper.58.1s.5","article-title":"Molecular insights into salicylate synthase: from medicinal chemistry perspective","volume":"58","author":"Bire","year":"2024","journal-title":"Ind J Pharmaceut Educ Res"},{"issue":"2","key":"10.1016\/j.tube.2025.102628_bib21","first-page":"1","article-title":"Unraveling the EthR puzzle: exploring novel inhibitors in the fight against tuberculosis from a medicinal chemistry vistas","volume":"7","author":"Chonde","year":"2004","journal-title":"EC Clin Med Case Reports"},{"key":"10.1016\/j.tube.2025.102628_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0074-02762004000100020","article-title":"Drug susceptibility testing of Mycobacterium tuberculosis by the broth microdilution method with 7H9 broth","volume":"99","author":"Coban","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.tube.2025.102628_bib23","series-title":"Antimycobacterial susceptibility testing for Mycobacterium tuberculosis; proposed standard M24-T","year":"1995"},{"key":"10.1016\/j.tube.2025.102628_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","article-title":"Determination of minimum inhibitory concentrations","volume":"48","author":"Andrews","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2025.102628_bib25","series-title":"NCCLS Approved standard M27-A","year":"1997"},{"key":"10.1016\/j.tube.2025.102628_bib26","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1074\/jbc.M414348200","article-title":"Structure and function of carbonic anhydrases from Mycobacterium tuberculosis","volume":"280","author":"Covarrubias","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tube.2025.102628_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.tube.2025.102628_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s11224-022-02046-3","article-title":"Investigation of structure activity relationship: in silico studies of [1,2,4]triazolo[4,3-a]pyridine ureas as P38 kinase inhibitors","volume":"34","author":"Choudhary","year":"2023","journal-title":"Struct Chem"},{"key":"10.1016\/j.tube.2025.102628_bib29","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1080\/07391102.2023.2204502","article-title":"Reconnoitering imidazopyridazines as anticancer agents based on virtual modelling approach: quantitative structure activity relationship, molecular docking and molecular dynamics","volume":"42","author":"Khandekar","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.tube.2025.102628_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2025.102628_bib31","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2025.102628_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bioorg.2019.01.065","article-title":"Click-tailed benzenesulfonamides as potent bacterial carbonic anhydrase inhibitors for targeting Mycobacterium tuberculosis and Vibrio cholerae","volume":"86","author":"Bua","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.tube.2025.102628_bib33","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1021\/acs.jmedchem.6b01718","article-title":"Rational design, synthesis, and biological evaluation of heterocyclic quinolones targeting the respiratory chain of Mycobacterium tuberculosis","volume":"60","author":"Hong","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2025.102628_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2013.10.082","article-title":"Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis","volume":"71","author":"Yempala","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2025.102628_bib35","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.3390\/molecules23112911","article-title":"Carbonic anhydrase inhibitors as novel drugs against mycobacterial \u03b2-carbonic anhydrases: an update on in vitro and in vivo studies","volume":"23","author":"Aspatwar","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.tube.2025.102628_bib36","article-title":"Phenanthrolinic analogues of quinolones show antibacterial activity against M","volume":"207","author":"Coulibaly","year":"2020","journal-title":"tuberculosis. Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.tube.2025.102628_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bmcl.2015.11.071","article-title":"Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent","volume":"26","author":"Shaikh","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.tube.2025.102628_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bmcl.2007.11.111","article-title":"Synthesis and antibiotic activity of a small molecules library of 1,2,3-triazole derivatives","volume":"18","author":"Aufort","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"issue":"14","key":"10.1016\/j.tube.2025.102628_bib39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2174\/1389557518666180718124858","article-title":"Novel benzylidenehydrazide-1,2,3-triazole conjugates as antitubercular agents: synthesis and molecular docking","volume":"19","author":"Shaikh","year":"2019","journal-title":"Mini Rev Med Chem"},{"issue":"29","key":"10.1016\/j.tube.2025.102628_bib40","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.2174\/138161210793429814","article-title":"The \u03b2-Carbonic anhydrases from mycobacterium tuberculosis as drug targets","volume":"16","author":"Nishimori","year":"2010","journal-title":"Cur Pharmaceut Des"},{"key":"10.1016\/j.tube.2025.102628_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bioorg.2019.01.065","article-title":"Click-tailed benzenesulfonamides as potent bacterial carbonic anhydrase inhibitors for targeting Mycobacterium tuberculosis and Vibrio cholerae","volume":"86","author":"Bua","year":"2019","journal-title":"Bioorg Chem"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297922500023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297922500023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T13:19:04Z","timestamp":1746105544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147297922500023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":43,"alternative-id":["S147297922500023X"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2025.102628","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative exploration of 2-phenylquinolin-4(1H)-one tethered 1,2,3-triazole derivatives: A comprehensive in vitro and in silico investigation towards novel anti-tubercular agents","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2025.102628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102628"}}